Purdue Claims Construction Prevails In Embeda IP Suit
A federal judge has largely adopted Purdue Pharma LP's proposed claims construction in a declaratory judgment suit brought by King Pharmaceuticals Inc. and Alpharma Inc. — the makers of oral opioid...To view the full article, register now.
Already a subscriber? Click here to view full article